Features Screener Stocks Charts
Sign In Sign Up

Ipca Laboratories Ltd. Income Statement

NSE:IPCALAB | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year IPCALAB income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 78.30B 90.32B
Cost of Revenue -25.76B -27.79B
Gross Profit 52.54B 62.54B
Sales, General & Admin -38.08B -44.35B
Operating Income 10.89B 14.21B
Profit Before Tax 8.43B 11.31B
Net Income 5.23B 7.85B
Diluted Shares 253.70M 253.67M
Diluted EPS 21.57 29.08

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025